[Oxcarbazepine in the treatment of drug-resistant epilepsy in children and adolescents: preliminary study].
A comparative study was conducted to evaluate the efficacy and tolerability of oxcarbazepine administration in patients with a diagnosed intractable epilepsy with simple partially and complex seizures secondarily generalised. There were 12 patients aged between 2-23 treated in Outpatients' Neurological Department for Children and Adolescents in Poznań. Oxcarbazepine was applied as an add-on therapy in all patients. The drug was administered in 3 daily dose. The doses of oxcarbazepine were evaluated as well as the occurrence of adverse effects was recorded. Four patients presented over 50% reduction of seizures. During the whole period of observation there was no occurrence of adverse effects associated with the inclusion of oxcarbazepine as add-on drug.